Cargando…

Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer

Background: Breast cancer currently affects more than two million women worldwide, and its incidence is steadily increasing. One of the most essential factors of invasion and metastasis of breast cancer cells is angiogenesis and non-angiogenic vascularization. Lenvatinib and Regorafenib share the sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajbouj, Khuloud, Qaisar, Rizwan, Alshura, Mohammed A., Ibrahim, Zeinab, Alebaji, Mohamad B., Al Ani, Amenah W., Janajrah, Hanadi M., Bilalaga, Mariah M., Omara, Abdelrahman I., Abou Assaleh, Rebal S., Saber-Ayad, Maha M., Elmoselhi, Adel B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028329/ https://www.ncbi.nlm.nih.gov/pubmed/35457226 http://dx.doi.org/10.3390/ijms23084408

Ejemplares similares

Unveiling the molecular Culprit of arterial stiffness in vitamin D deficiency and obesity: Potential for novel therapeutic targets
por: Elmoselhi, Adel B., et al.
Publicado: (2023)

Iron Overload Induces Oxidative Stress, Cell Cycle Arrest and Apoptosis in Chondrocytes
por: Karim, Asima, et al.
Publicado: (2022)

Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines
por: Sasaki, Reina, et al.
Publicado: (2020)

Signature molecular changes in the skeletal muscle of hindlimb unloaded mice
por: Azeem, Muhammad, et al.
Publicado: (2021)

Vitamin D Exerts Significant Antitumor Effects by Suppressing Vasculogenic Mimicry in Breast Cancer Cells
por: Bajbouj, Khuloud, et al.
Publicado: (2022)

Effect of Microgravity Environment on Gut Microbiome and Angiogenesis
por: Siddiqui, Ruqaiyyah, et al.
Publicado: (2021)

Effect of Microgravity on the Gut Microbiota Bacterial Composition in a Hindlimb Unloading Model
por: Siddiqui, Ruqaiyyah, et al.
Publicado: (2022)

Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets
por: Bajbouj, Khuloud, et al.
Publicado: (2021)

PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells
por: Bajbouj, Khuloud, et al.
Publicado: (2021)

CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinoma
por: Zheng, Adi, et al.
Publicado: (2019)

Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study
por: Xu, Yongkang, et al.
Publicado: (2023)

PD-1 inhibitors plus lenvatinib versus PD-1 inhibitors plus regorafenib in patients with advanced hepatocellular carcinoma after failure of sorafenib
por: Xu, Yongkang, et al.
Publicado: (2022)

Lenvatinib enhances antitumor immunity by promoting the infiltration of TCF1 (+) CD8 (+) T cells in HCC via blocking VEGFR2
por: Mei, Zhibin, et al.
Publicado: (2023)

High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines
por: Bajbouj, Khuloud, et al.
Publicado: (2018)

Estrogen-dependent disruption of intracellular iron metabolism augments the cytotoxic effects of doxorubicin in select breast and ovarian cancer cells
por: Bajbouj, Khuloud, et al.
Publicado: (2019)

Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation
por: Eschbach, Ralf Stefan, et al.
Publicado: (2017)

Sophoridine suppresses lenvatinib‐resistant hepatocellular carcinoma growth by inhibiting RAS/MEK/ERK axis via decreasing VEGFR2 expression
por: Zhao, Zhongwei, et al.
Publicado: (2020)

Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma
por: Kwok, Christopher, et al.
Publicado: (2023)

Role of Matrix Metalloproteinases in Angiogenesis and Its Implications in Asthma
por: Bajbouj, Khuloud, et al.
Publicado: (2021)

Erythema multiforme induced by regorafenib
por: Matsunaga, Mototsugu, et al.
Publicado: (2017)

Estrogen Signaling Induces Mitochondrial Dysfunction-Associated Autophagy and Senescence in Breast Cancer Cells
por: Bajbouj, Khuloud, et al.
Publicado: (2020)

Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022
por: Khan, Husain Yar, et al.
Publicado: (2023)

Interaction Between Sex and Organic Anion‐Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib‐N‐Oxide and Regorafenib‐Glucuronide in Mice
por: Fu, Qiang, et al.
Publicado: (2019)

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage
por: Yamamoto, Yuji, et al.
Publicado: (2014)

Targeting gastrointestinal stromal tumors: the role of regorafenib
por: Schroeder, Brett, et al.
Publicado: (2016)

Unusual Presentation of a Hemiplegic Migraine in a Seven-Year-Old Child: A Case Report
por: Alebaji, Mohamad B, et al.
Publicado: (2023)

The Role of ATP-Binding Cassette Subfamily A in Colorectal Cancer Progression and Resistance
por: Alketbi, Latifa, et al.
Publicado: (2023)

Hindlimb unloading induces time-dependent disruption of testicular histology in mice
por: Karim, Asima, et al.
Publicado: (2022)

Incidence and risk of regorafenib-induced hepatotoxicity
por: Zhao, Bin, et al.
Publicado: (2017)

Experience with regorafenib in the treatment of hepatocellular carcinoma
por: Granito, Alessandro, et al.
Publicado: (2021)

Characterization of Glioblastoma Cells Response to Regorafenib
por: Mongiardi, Maria Patrizia, et al.
Publicado: (2022)

Oncogenic Potential of Bisphenol A and Common Environmental Contaminants in Human Mammary Epithelial Cells
por: Nair, Vidhya A, et al.
Publicado: (2020)

Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma
por: Chiesa, Silvia, et al.
Publicado: (2022)

Quantification of cobimetinib, cabozantinib, dabrafenib, niraparib, olaparib, vemurafenib, regorafenib and its metabolite regorafenib M2 in human plasma by UPLC–MS/MS
por: Krens, Stefanie D., et al.
Publicado: (2020)

Culturally Adapting a Digital Intervention to Reduce Suicidal Ideation for Syrian Asylum Seekers and Refugees in the United Kingdom: Protocol for a Qualitative Study
por: Beuthin, Oliver, et al.
Publicado: (2023)

Intestinal Perforation as a Paradoxical Reaction to Tuberculosis
por: Alebaji, Mohamad B
Publicado: (2022)

Correction: Intestinal Perforation as a Paradoxical Reaction to Tuberculosis
por: Alebaji, Mohamad B
Publicado: (2022)

Defective Autophagosome Formation in p53-Null Colorectal Cancer Reinforces Crocin-Induced Apoptosis
por: Amin, Amr, et al.
Publicado: (2015)

Prevention and management of adverse events related to regorafenib
por: De Wit, Mieke, et al.
Publicado: (2013)

Correction: Incidence and risk of regorafenib-induced hepatotoxicity
por: Zhao, Bin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7sgc167tp35fpldbroamr51hk0